Societe des Produits Nestle S.A., Ten Percent Owner at Aimmune Therapeutics, holds 11.11M shares in Axcella Health (Ticker: AXLA), holds 525.63K shares in Aimmune Therapeutics (Ticker: AIMT). Most recently, Societe des Produits Nestle S.A. Bought ― shares of Axcella Health on Oct 17, 2022 for an estimated value of 6.00M.
Societe des Produits Nestle S.A. insider profile FAQ
What is the percentage of profitable transactions made by Societe des Produits Nestle S.A.?
The percentage of profitable transactions made by Societe des Produits Nestle S.A. is 0%.
What is the average return per transaction made by Societe des Produits Nestle S.A.?
The average return per transaction made by Societe des Produits Nestle S.A. is -76.60%.
What stocks does Societe des Produits Nestle S.A. hold?
Societe des Produits Nestle S.A. holds: AIMT, AXLA stocks.
What was Societe des Produits Nestle S.A.’s latest transaction?
Societe des Produits Nestle S.A. latest transaction was an Informative Buy of $6.00M.
What was Societe des Produits Nestle S.A.'s most profitable transaction?
Societe des Produits Nestle S.A.’s most profitable transaction was an Informative Buy of AXLA stock on March 16, 2022. The return on the trade was -75.70%.
What is Societe des Produits Nestle S.A.'s role in Aimmune Therapeutics?
Societe des Produits Nestle S.A.'s role in Aimmune Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.